SecBot SecBot
8-K ·Filed May 11, 2026

HIMS

Hims & Hers Health, Inc.
BEARISH
Impact 7/10
Horizonweeks Processed5mo ago SEC0001773751-26-000074
8-K Item 2.02: Earnings release
Actionable Insight ▼ Bearish

The 4% revenue growth and 8% US revenue decline signal a severe growth deceleration from the 59% pace of 2025. The GLP-1 strategic pivot introduces execution risk and margin compression. Watch for Q2 2026 revenue guidance of $680M-$700M — the midpoint implies ~12% sequential growth, which will be the key test of whether the branded GLP-1 strategy can re-accelerate the business. The lowered EBITDA guidance suggests margins will remain under pressure.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
HIMS ▲ +18.50% at T+60d
SHORT call ✗ call lost -18.50% · α vs SPY -14.11% · entry $25.03 → $29.66
Entry = T+0 close
May 11, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.54%
$25.03
settled 6mo ago
T+5d
-10.95%
call +10.95% · α +11.02%
$22.29
settled 5mo ago
T+20d
+10.99%
call -10.99% · α -12.71%
$27.78
settled 5mo ago
T+60d
+18.50%
call -18.50% · α -14.11%
$29.66
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Hims & Hers reported Q1 2026 revenue of $608.1M (+4% YoY), a sharp deceleration from 59% growth in FY2025, with a GAAP net loss of $92.1M vs. net income of $49.5M a year ago. The company raised full-year 2026 revenue guidance to $2.8B-$3.0B (from $2.7B-$2.9B), but lowered Adjusted EBITDA guidance to $275M-$350M (from $300M-$375M), and disclosed a strategic pivot away from compounded GLP-1s toward branded products, incurring $33.5M in restructuring charges.

Key Financial Metrics

EPS
−$0.40
est $0.04 · -1100.0%
Revenue
$608.1M
est $616.9M · -1.4% · +4.0% YoY
Rating
strong miss
Guidance
$2.8B-$3.0B
raised
Free Cash Flow
$53.0M
Gross Margin
65%

Key Facts

  • Q1 2026 revenue $608.1M, up only 4% YoY vs 59% growth in FY2025
  • GAAP net loss of $92.1M vs net income of $49.5M in Q1 2025
  • Gross margin contracted to 65% from 73% a year ago
  • Adjusted EBITDA fell to $44.3M from $91.1M, margin halved to 7% from 16%
  • US revenue declined 8% YoY to $529.9M; Rest of World grew 969% to $78.2M
  • Monthly Revenue per Average Subscriber fell 6% YoY to $80
  • Full-year 2026 revenue guidance raised to $2.8B-$3.0B, but Adjusted EBITDA guidance lowered to $275M-$350M
  • Strategic pivot from compounded GLP-1s to branded products triggered $33.5M in restructuring charges and $15M legal settlement costs
  • Operating cash flow declined to $89.4M from $109.1M YoY
  • Accumulated deficit widened to $205.9M from $113.8M at year-end 2025

Financial Impact

Q1 net loss of $92.1M vs prior-year net income of $49.5M; Adjusted EBITDA down 51% to $44.3M; $33.5M restructuring charge from GLP-1 strategic pivot

revenuenet incomegross marginadjusted EBITDAoperating cash flow

Risk Factors

  • GLP-1 strategic pivot execution risk — transition from compounded to branded products may pressure margins further
  • US revenue declining 8% YoY signals potential market share loss or demand saturation in core domestic business
  • Adjusted EBITDA guidance lowered by $25M at midpoint despite higher revenue guidance, indicating structural margin compression
  • Legal settlement costs of $15M and restructuring charges may recur
  • Accumulated deficit growing and negative GAAP profitability raises balance sheet concerns

Market Snapshot

Exchange
NYSE
Sector
Services-Offices & Clinics of Doctors of Medicine
Analyst Consensus
43% bullish (23 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001773751-26-000074
Document: hims-20260511.htm0001773751-26-000074
Document: 0001773751-26-000074-index-headers.html0001773751-26-000074
Document: 0001773751-26-000074-index.html0001773751-26-000074
Document: 0001773751-26-000074.txt0001773751-26-000074
8-K Data (Synthetic)0001773751-26-000074
18 reports for HIMS
Performance horizon
75% Hit rate @ T+20 3 of 4 directional calls Went positive at some point 3 of 4 best @ T+20▲ +36.57%Jun 2, 2026
Filters
Rows
Reports for HIMS — sortable, filterable
TypeNow
Oct 7, 2026
19d ago
8-K
NEUTRAL ★ 3/10
$28.06awaiting T+20—$27.59 (−1.67%)
Sep 23, 2026
4w ago
Insider Cluster
BEARISH ★ 5/10
$29.28 $29.13▲ +0.51%▲ +0.09%$27.59 (+5.77%)
Sep 18, 2026
5w ago
Insider Cluster
BEARISH ★ 4/10
$29.35 $28.15▲ +4.09%▲ +3.18%$27.59 (+6.00%)
Sep 17, 2026
5w ago
Insider Cluster
BEARISH ★ 4/10
$27.99 $28.07▼ −0.29%▼ −0.08%$27.59 (+1.43%)
Aug 20, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.78 $29.35▼ −13.11%▼ −14.13%$27.59 (−18.32%)
Aug 20, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.78 $29.35▼ −13.11%▼ −14.13%$27.59 (−18.32%)
Aug 18, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$31.09 $27.89▼ −10.29%▼ −9.45%$27.59 (−11.26%)
Aug 10, 2026
11w ago
8-K
MIXED ★ 7/10
$30.51 $27.90▼ −8.55%▼ −7.50%$27.59 (−9.57%)
Jul 1, 2026
16w ago
8-K
NEUTRAL ★ 5/10
$36.80 $27.04▼ −26.52%▼ −26.11%$27.59 (−25.03%)
Jun 17, 2026
18w ago
Insider Cluster
NEUTRAL ★ 2/10
$35.47 $33.68▼ −5.05%▼ −5.58%$27.59 (−22.22%)
Showing 10 of 18

US Market Status

Market Closed — Opens in 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 11, 2026